Stock screenerAll disclosures →
EDGAR →
DRTS
Conviction 82HealthcareScan · Thu, Jun 25, 2026Bullish marubozu
DRTS$11.16+11.04%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 692.49K
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +200.00%· 3 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price11.16
Change+11.04%
Gap+0.10%
Rel volume1.10×
Avg volume991.43K
Avg $ vol9.89M
SMA 209.82
SMA 509.26
SMA 2006.46
Price vs 50+20.51%
Price vs 200+72.68%
MA stackbullish
50/200 cross—
Supertrendup · 8.41
RSI (14)63
MACD hist0.06
MACD crossbull · 0d
Stoch %K / %D98 / 63
ADX (14)22
+DI / −DI29 / 15
RSI divergence—
MACD divergence—
ATR %+7.10%
ADR %8.35%
52w high11.18
52w low2.90
From 52w high-0.18%
Above 52w low+284.83%
New 52w highYes
SqueezeOn · 4d
Bollinger width22.63%
%B1.10
Donchian pos93.41%
Donchian high11.33
Donchian low8.75
AVWAP (52w high)10.08
vs AVWAP high+10.67%
AVWAP (52w low)8.09
vs AVWAP low+37.88%
OBV trendFlat
Chaikin MF (20)-0.08
Today vs 20d1.10×
Avg vol (14d)692.49K
Avg vol (20d)991.43K
Avg $ vol (20d)9.89M
Market cap982.19M
RS 3m (vs SPY)+31.11%
RS 6m (vs SPY)+90.49%
RS line new highNo
Trend template8/8
Technical rank93.7
1 week+16.13%
1 month+7.62%
3 months+58.07%
6 months+118.82%
1 year+275.76%
YTD+131.06%
P/E—
P/B12.74
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.00
Current7.45
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target13.50
Target upside20.97%
Analyst ratingBuy
Institutional4.61%
Ent. value969.99M
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out90.33M
Employees121
ListedTue, Mar 8, 2022
Free float46.86M
Float %53.2%
Short interest1.79M
Days to cover2.0d
Short volume38.4%
Squeeze score19 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.26 vs −$0.13
Last surprise-100.0% miss
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank93.7 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish marubozu
News sentiment—
Congress activity
Disclosed STOCK Act trades in DRTS
No recent disclosed trades by Congress in DRTS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DRTS · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-23 | Sell | 15K | $142K | 2026-06-23 | 2026-06-25 |
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-23 | Sell | 2.5K | $25K | 2026-06-23 | 2026-06-25 |
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-03 | Sell | 17.5K | $191K | 2026-06-03 | 2026-06-04 |
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-03 | Sell | 15K | $161K | 2026-06-03 | 2026-06-04 |
SEC filings
EDGAR filings in DRTS · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.